Sei Investments CO C4 Therapeutics, Inc. Transaction History

Sei Investments CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$2.75 - $3.77 $2,642 - $3,622	-961 Reduced 7.91%	11,191 $30,000
Q1 2023 May 12, 2023	BUY	$3.1 - $9.02 $2,842 - $8,271	917 Added 8.16%	12,152 $38,000
Q4 2022 Feb 10, 2023	SELL	$5.42 - $10.24 $1,983 - $3,747	-366 Reduced 3.15%	11,235 $66,000
Q3 2022 Nov 14, 2022	BUY	$8.03 - $12.77 $93,156 - $148,144	11,601 New	11,601 $102,000

130

63.5M

670K

54.8K

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $208M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.